{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Except for the water that dripped from his ceiling when it rained, Adam White, a young lawyer, loved the tiny studio he found a decade ago on the top floor of a five-story walk-up on East 83rd Street. It was only $590 a month and protected by rent stabilization. So after the landlord tried and failed to stop the leaks over several years, Mr. White withheld two months' rent and demanded that they finally be fixed. The landlord filed an eviction notice in Housing Court, but the two sides soon came to an agreement. Mr. White received a rebate on his rent, and a promise of a more thorough repair job. The landlord dropped the court case, and it was dismissed.", "headline": {"main": "Residential Real Estate; Suit Disputes the Accuracy of Tenant Screening Reports"}, "abstract": "Class-action suit is filed against First American Registry, tenant-screening company, seeking to require it to provide updated, accurate information in its reports; says reports show any lawsuits filed against tenants in New York City Housing Court and elsewhere, but often do not show final disposition of cases (M)", "print_page": "8", "word_count": 794, "_id": "4fd235218eb7c8105d7c65ea", "snippet": "Except for the water that dripped from his ceiling when it rained, Adam White, a young lawyer, loved the tiny studio he found a decade ago on the top floor of a five-story walk-up on East 83rd Street. It was only $590 a month and protected by rent...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/02/27/nyregion/residential-real-estate-suit-disputes-the-accuracy-of-tenant-screening-reports.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "organizations", "value": "FIRST AMERICAN REGISTRY"}, {"name": "subject", "value": "HOUSING"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DECISIONS AND VERDICTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Josh", "lastname": "BARBANEL"}], "original": "By JOSH BARBANEL"}, "document_type": "article", "pub_date": "2004-02-27T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "After I was diagnosed with Parkinson's disease two years ago, at the relatively young age of 52, I read everything I could about the condition's usual ''progression'' -- an odd word for degeneration. The worst-case prognosis is grim: a long slide into physical and mental incapacity. That is not going to happen to me, I said, as I began measuring my physical decline. I am young enough that I may be able to benefit from advances in medicine, especially in brain research. Maybe with new medications I would be able to put off taking L-dopa, the best drug for Parkinson's but one that loses its effectiveness over time. Surely better treatments will become available, I told myself.", "headline": {"main": "The Triumph of Hope Over Science"}, "abstract": "Mark Derr Op-Ed article holds, as Parkinson's disease sufferer, that scientists are putting forth overly optimistic list of potential benefits of human cloning as source of stem cells to treat diseases, including Parkinson's; says invocation of human suffering to justify cloning and other ethically controversial procedures is disingenuous and unfair; notes possiblity of health benefits seems remote; calls for worldwide moratorium on human cloning; drawing (M)", "print_page": "23", "word_count": 782, "_id": "4fd23c0a8eb7c8105d7d0ea3", "snippet": "After I was diagnosed with Parkinson's disease two years ago, at the relatively young age of 52, I read everything I could about the condition's usual ''progression'' -- an odd word for degeneration. The worst-case prognosis is grim: a long slide...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/02/25/opinion/the-triumph-of-hope-over-science.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "STEM CELLS"}, {"name": "subject", "value": "CLONING"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "REPRODUCTION (BIOLOGICAL)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "PARKINSON'S DISEASE"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Mark", "lastname": "Derr"}], "original": "By Mark Derr"}, "document_type": "article", "pub_date": "2004-02-25T00:00:00Z", "section_name": "Health; Opinion"}], "meta": {"hits": 2, "offset": 0, "time": 27}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}